HBV/HDV - ACT Connect Summit | Sunday, March 26, 2023

March 26, 2023

Thank you for joining us at the HBV/HDV - ACT Connect Summit at the Third Annual Liver Connect conference!

Please select “Register/Take Course” to complete the following:

  • Pre-Test
  • Post-Test
  • Program Evaluation

Upon completion, you will receive your accreditation certificate. 

The pre-test will close on Sunday, March 26, at 7:00 AM PT.
The post-program activities will become available on Sunday, March 26, at 10:00 AM PT.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe HBV/HDV management recommendations/guidelines for new treatments and describe current guidelines for the diagnosis and management of gastrointestinal disorders.
  • Utilize new therapies and employ an evidence-based approach to the management of gastrointestinal disorders to optimize treatment results for patients with HBV/HDV.
  • Identify new advances and assess their potential impact on clinical practice.
Course summary
Available credit: 
  • 2.75 AMA PRA Category 1 Credit
  • 2.75 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
Course expires: 
Event starts: 
03/26/2023 - 10:00am EDT
Event ends: 
03/26/2023 - 1:00pm EDT

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Chronic Liver Disease Foundation (CLDF). Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Purdue University College of Pharmacy designates this Live Activity for a maximum of 3.75 AMA PRA Category 1 Credits™ on Saturday, March 25, 2023, and 2.75 AMA PRA Category 1 Credits™ on Sunday, March 26, 2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

All relevant conflicts of interest have been mitigated prior to the start of the activity.

None of the planners, reviewers, CLDF staff, and Purdue University College of Pharmacy staff have a relevant financial relationship(s) with ineligible companies to disclose unless listed below.

This activity is jointly provided by the Purdue University College of Pharmacy
and the Chronic Liver Disease Foundation.

This activity is supported by an educational grant from Gilead Sciences, Inc.

Available Credit

  • 2.75 AMA PRA Category 1 Credit
  • 2.75 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.